Antimicrobial mixtures used by tissue banks for harvested skin: Comparative in vitro activity

Burns

Volumn 24, Issue 7, 1998, Pages 604-608

  Holder, I A ^a,b   Robb, E ^a,c   Kagan, R ^a,b,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c Ohio Valley Tissue Skin Center   (United States)

Author keywords

Antimicrobial agents; Quality assurance; Tissue banking

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; BURN; DRUG EFFICACY; HUMAN; SKIN CULTURE; TISSUE PRESERVATION; YEAST;

ANTI-BACTERIAL AGENTS; BURNS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; SKIN; TISSUE BANKS; TISSUE PRESERVATION;

EID: 0032214408     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(98)00075-8     Document Type: Article

References (15)

1. Gey G.O., Gey M.K., Inui F., Vedder H. Effects of crude and purified penicillin on continuous cultures of normal and malignant cells. Bull Johns Hopkins Hosp. 77:1945;116-131.
2. Pomerat C.M. Studies on Penicillium notatum in tissue cultures. Texas Acad Sci Proc Trans (1944). 28:1945;130-132.
3. Rose H.M., Malloy E., O'Neill E. Effect of penicillin on bacterial contamination of eggs and tissue cultures inoculated with unfiltered sputums. Proc Soc Exp Biol Med. 60:1945;23-25.
4. Perlman D. Use of antibiotics in cell culture media. Methods Enzymol. LVIII:1979;110-116.
5. Holder I.A., Boyce S.T. Agar well diffusion assay testing of bacterial susceptibility to various antimicrobials in concentrations non-toxic for human cells in cultures. Burns. 20:1994;426-429.
6. Nathan P., Law E.J., Murphy D.F., MacMillan B.G. A laboratory method for selection of topical antimicrobial agents to treat infected burn wounds. Burns. 4:1978;177-187.
7. Col N.F., O'Connor R.W. Estimating worldwide current antibiotic usage: report of task force 1. Rev Infect Dis. 9(S3):1987;S232-S243.
8. Figueredo V.M., Neu H.C. Synergy of ciprofloxacin and fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis. J Antimicrob Chemother. 22:1988;41-50.
9. DuPont H.L., Steele J.H. Use of antimicrobial agents in animal feeds: implications for human health. Rev Infect Dis. 9:1987;447-460.
10. Bates J., Jordens J.Z., Griffiths D.T. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother. 34:1994;507-516.
11. Endtz H.P., Ruijs G.J., van Klingeren B., Jansen W.H., van der Reyden T., Mouton P. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother. 27:1991;199-208.
12. Rybak M.J., Palmer S.M. Vancomycin-resistant enterococci. Pharmacotherapy. 5:1995;684-685.
13. Leclercq R., Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis. 24:1997;545-546.
14. Eliopoulos G.M. Increasing problems in the therapy of enterococcal infections. Eur J Clin Microbiol Infect Dis. 12:1993;409-412.
15. CDC. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Control Practice Advisory Committee (HICPAC). MMWR 1994; 44/NORR12: 1-13.